Neuroendocrine Neoplasms
Oncology·MeSH: Hypertension
Prevalence
30.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
Frequently asked questions
How many drugs are in development for Neuroendocrine Neoplasms?
BioSniper tracks 1 drug in development for Neuroendocrine Neoplasms across 1 company.
How many clinical trials target Neuroendocrine Neoplasms?
There are 1 clinical trial targeting Neuroendocrine Neoplasms tracked by BioSniper.
What is the prevalence of Neuroendocrine Neoplasms?
The estimated prevalence of Neuroendocrine Neoplasms is approximately 30.0 per 100,000 population.
Deep-dive into Neuroendocrine Neoplasms
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis